WC
BSX icon

Wexford Capital’s Boston Scientific BSX Stock Holding History

Wexford Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,935
Closed -$1.31K – 161
2021
Q4 		$1.31K Buy
+30,935
New +$1.3M 0.05% 95
2020
Q4 		– Sell
-21,999
Closed -$841K – 312
2020
Q3 		$841K Sell
21,999
-205,877
-90% -$7.93M 0.23% 76
2020
Q2 		$8M Buy
227,876
+39,658
+21% +$1.43M 2.01% 16
2020
Q1 		$6.14M Sell
188,218
-143,127
-43% -$5.59M 2.27% 12
2019
Q4 		$15M Buy
+331,345
New +$13.9M 2.31% 8
2016
Q3 		– Sell
-183,767
Closed -$4.29M – 162
2016
Q2 		$4.29M Buy
+183,767
New +$3.98M 0.75% 49

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Wexford Capital's BSX Position: Q1 2022 in Review

Wexford Capital sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 30,935 shares — an estimated $1.31K sold.

Wexford Capital first reported a position in BSX in Q2 2016 and held it in 6 quarters. The position peaked at $15M in Q4 2019. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Wexford Capital reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Wexford Capital sold 30,935 Boston Scientific shares in Q1 2022, an estimated $1.31K.
  • Wexford Capital first reported a position in Boston Scientific in Q2 2016 and held it in 6 quarters.
  • Wexford Capital's Boston Scientific position peaked at $15M in Q4 2019.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Wexford Capital's 13F filing for Q1 2022, filed 13 May 2022.